Delivery Order SPE2DB20D2104-SPE2DB23FU71Z

Award Date 8/4/23
Potential Completion Date 8/7/23
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $11,824.35, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order with a firm fixed price pricing type, and the ultimate completion date is August 27, 2024. The contract is not designated as a set-aside....
This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension 7.5 mL to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,650.72, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of September 25, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension (7.5 mL) to the Defense Logistics Agency (DLA). The $3,215.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 8, 2024 and was awarded on February 7, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Cipro-Dexameth otic suspension (7.5 mL) to the Defense Logistics Agency (DLA). The $10,431.85 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 1, 2021, with a completion date of September 2, 2021. This delivery order falls under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension (7.5 ml) to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2021 with a ceiling value of $4,314.36. The contract is a Delivery Order under a Firm Fixed Price contract type, with no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite...
This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,311.84 and an ultimate completion date of May 7, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $6,075.52 with a completion date of April 24, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and...
This federal contract award is for the delivery of a pharmaceutical product, Ciproflox-Dexameth Otic Suspension, to the Defense Logistics Agency (DLA). The contract, valued at $4,767.76, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed-price delivery order with a completion date of September 16, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension 7.5mL to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $1,634.12, is a firm-fixed price delivery order with a completion date of December 19, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a ceiling value of $1,156.08 and a performance period through April 5, 2024. Amerisourcebergen Drug Corp...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FU71Z
    Delivery Order

This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,443.90 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 7, 2023. This award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 11:11 AM